Instituto Universitario de Investigación en Neuroquímica
Centro/Instituto
National Institutes of Health
Bethesda, Estados UnidosPublicaciones en colaboración con investigadores/as de National Institutes of Health (7)
2022
-
ATXN2 intermediate expansions in amyotrophic lateral sclerosis
Brain : a journal of neurology, Vol. 145, Núm. 8, pp. 2671-2676
2020
-
Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease
eLife, Vol. 9
-
Update of P2Y receptor pharmacology: IUPHAR Review 27
British Journal of Pharmacology, Vol. 177, Núm. 11, pp. 2413-2433
2018
-
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene
Neuron, Vol. 97, Núm. 6, pp. 1268-1283.e6
2016
2012
-
Guidelines for the use and interpretation of assays for monitoring autophagy
Autophagy, Vol. 8, Núm. 4, pp. 445-544